MedPath

Effects of Lifestyle Intervention on Childhood Outcomes in LGA Infants

Not Applicable
Recruiting
Conditions
Childhood Overweight
Interventions
Other: Comprehensive lifestyle intervention
Registration Number
NCT04661449
Lead Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Brief Summary

Large-for-gestational-age (LGA) infants have a higher risk of metabolic disease later in life, and their postnatal growth in early childhood may be associated with long-term adverse outcomes. The purpose of this study is to explore whether comprehensive lifestyle intervention in the first year after birth in LGA infants will reduce the rate of overweight/obesity at childhood and improve neurodevelopmental outcomes and its possible mechanism.

Detailed Description

Term LGA infants will be randomly divided into two groups shortly after birth: intervention group and control group. Infants in intervention group will attend the follow-up clinic and motor development assessment and guidance will be provided every three months in the first year. Other lifestyle interventions include feeding guidance and healthcare education. Infants in control group will routinely attend the follow-up clinic every six months. Primary outcome is the rate of overweight/obesity at two years old and seven years old. Neurodevelopmental assessment, carotid intima-media thickness (CIMT) and blood pressure at childhood will also be evaluated. The association of the outcome of LGA infants at two years old and the biomarkers in cord blood will be investigated, which includes serum leptin, insulin, insulin-like growth factors -1 (IGF-1), blood lipid series and adiponectin.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
138
Inclusion Criteria
  • term
  • large-for-gestational-age infants
Exclusion Criteria
  • major genetic disorder
  • congenital anomalies
  • severe digestive disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lifestyle InterventionComprehensive lifestyle interventionevery 3 months within 1 year.
Primary Outcome Measures
NameTimeMethod
Rate of overweight/obesity at 7 years oldat 7 years old

Weight and height will be combined to report BMI in kg/m\^2. According to the intergrowth-21st age-specific BMI standard issued in 2014, BMI ≥ 85th percentile is defined as overweight; BMI ≥ 95th percentile is defined as obesity

Rate of overweight/obesity at 2 years oldat 2 years old

Weight and height will be combined to report BMI in kg/m\^2. According to the intergrowth-21st age-specific BMI standard issued in 2014, BMI ≥ 85th percentile is defined as overweight; BMI ≥ 95th percentile is defined as obesity

Secondary Outcome Measures
NameTimeMethod
Neurodevelopmental assessment at 2 years oldat 2 years old

Bayley III's assessment of infants is divided into five areas: cognition, language, body movement, social emotion and adaptive behavior.

Association of BMI at 2 years old with biomarkers in cord bloodat 2 years old

Biomarkers include: serum leptin, insulin, IGF - Ⅰ, blood lipid series, adiponectin

Association of BMI at 7 years old with biomarkers in cord bloodat 7 years old

Biomarkers include: serum leptin, insulin, IGF - Ⅰ, blood lipid series, adiponectin

Carotid intima-media thickness (CIMT) at 2 years oldat 2 years old

Carotid intima-media thickness (CIMT) will be measured by experienced Pediatric Cardiologist.

Blood pressure at 7 years oldat 7 years old

Blood pressure will be measured by experienced nurses.

Carotid intima-media thickness (CIMT) at 7 years oldat 7 years old

Carotid intima-media thickness (CIMT) will be measured by experienced Pediatric Cardiologist.

Trial Locations

Locations (1)

Xinhua Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath